U.S. Narrows Childhood Vaccine Recommendations, Prompting Sharp Criticism From Pediatric Experts

BY EMMANUEL OGBONNA

The United States on Monday dramatically scaled back the number of vaccines it broadly recommends for all children, an unprecedented shift in public health policy that immediately reshapes the nation’s childhood immunization schedule and has drawn fierce opposition from pediatricians and infectious disease experts.

Under the new guidance, which took effect without delay, the Centers for Disease Control and Prevention will recommend routine vaccination against 11 diseases, down from the previous list that included protections against several additional illnesses. Vaccines no longer recommended for all children include those for influenza, rotavirus, hepatitis A, hepatitis B, certain forms of meningococcal disease, and respiratory syncytial virus, or RSV. Instead, immunization against those diseases will now be advised only for children considered at higher risk or when parents and physicians agree through what officials describe as shared clinical decision-making.

Administration officials said families who want those vaccines will still be able to receive them and that insurance coverage will remain in place. They argued the change is intended to simplify guidance and restore confidence in public health recommendations. Medical organizations, however, warned that narrowing the list could create confusion for parents, weaken vaccine uptake and lead to increases in illnesses that have long been preventable.

The shift follows a directive issued by President Donald Trump in December instructing the Department of Health and Human Services to review how other developed nations structure their vaccine schedules and to consider aligning U.S. guidance more closely with international norms. Health officials said an internal comparison with 20 peer countries concluded that the United States stood out for both the number of vaccines and the total doses recommended universally for children.

HHS officials framed the overhaul as a recalibration rather than a retreat, saying it focuses public messaging on what they view as the most essential protections while allowing flexibility for families and clinicians. Vaccines that remain recommended for all children include those protecting against measles, whooping cough, polio, tetanus, chickenpox and human papillomavirus.

Health Secretary Robert F. Kennedy Jr., who has long advocated for a narrower vaccine schedule, said the new approach would strengthen public trust. “This decision protects children, respects families, and rebuilds trust in public health,” he said in a statement.

Many medical experts strongly disagreed, criticizing both the substance of the changes and the way they were made. Pediatricians noted that vaccines removed from the universal list prevent diseases that still circulate widely in the United States and that can cause serious illness, hospitalization and death, particularly among infants and young children.

Dr. Sean O’Leary of the American Academy of Pediatrics said vaccine policies are carefully tailored to each country’s disease patterns, health infrastructure and population risks. “You can’t just copy and paste public health,” he said, warning that altering recommendations without a transparent review of evidence puts children at risk. “Literally children’s health and children’s lives are at stake.”

The updated guidance also changes recommendations for the HPV vaccine, reducing the number of doses for most children to a single shot, depending on age, rather than the previously advised two or three. Experts said that change, too, was made without public discussion or a detailed explanation of the supporting data.

Senior officials at HHS acknowledged that the revisions were implemented without input from the advisory committee that traditionally reviews and votes on changes to the childhood vaccine schedule. Those officials spoke on condition of anonymity, citing restrictions on discussing internal deliberations.

Public health specialists said bypassing that process undermines confidence in the recommendations and breaks with decades of precedent. Michael Osterholm, director of the Vaccine Integrity Project at the University of Minnesota, said removing routine recommendations for vaccines that protect against influenza, hepatitis and rotavirus, while also altering HPV guidance, could have serious consequences. He warned that the absence of a public process to weigh risks and benefits is likely to result in more hospitalizations and preventable deaths among children.

The policy change marks one of the most significant revisions to U.S. vaccination guidance in decades and comes amid broader debates over public trust in health institutions. As pediatricians and health officials digest the new rules, many say the long-term impact will hinge on how parents interpret the changes and whether vaccination rates remain high enough to prevent outbreaks of diseases once kept firmly in check.